Hale uses the research behind QRISK®3 to analyze your cardiovascular risk factors to determine your lifetime risk, and how you can improve your habits to live even longer.
QRISK3 has been featured in:

Valid for: Adults aged 25–84 without existing cardiovascular disease
What it does: Estimates lifetime cardiovascular disease risk and compares it with optimized risk factors (smoking, BMI, cholesterol, blood pressure)
How it works: Hale’s cardiovascular risk engine incorporates validated algorithms such as QRISK®3, developed by Endeavour Predict, to assess lifetime risk of heart disease.

